Skip to content

COVID-19 Induced Telogen Effluvium

COVID-19 Induced Telogen Effluvium

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04834102
Enrollment
200
Registered
2021-04-06
Start date
2021-01-27
Completion date
2021-04-27
Last updated
2021-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia, Covid19, SARS-CoV Infection, Telogen Effluvium

Keywords

Telogen Effluvium, Covid-19, Alopecia

Brief summary

This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection

Detailed description

Telogen effluvium (TE) is one of the most common causes of non-scarring alopecia. During the COVİD-19 pandemic, there is an increased number of Telogen effluvium patients.This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection and correlation between the severity of covid-19 and TE.

Interventions

DIAGNOSTIC_TESTBlood Tests

Evaluation of blood ferritin, hemoglobine, serum iron and serum iron binding capacity

Sponsors

Istanbul Medeniyet University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Sars-CoV-2 infection in the past year

Exclusion criteria

* Other common causes of Telogen effluvium ( such as anemia, iron deficiency, thyroid dysfunction)

Design outcomes

Primary

MeasureTime frameDescription
Hair shedding3 monthsPhysical examination of hair and scalp, trichoscopy, hair pull test

Countries

Turkey (Türkiye)

Contacts

Primary ContactUmut Mert YILDIRIM, Dr.
umutmertyildirim@gmail.com+905423383842
Backup ContactHasan AKSOY, Dr.
haxoil@yahoo.com+905053005460

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026